HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
about
Harvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury.Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis.Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.
P2860
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@ast
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@en
type
label
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@ast
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@en
prefLabel
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@ast
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@en
P2093
P2860
P1476
HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
@en
P2093
Daniel J Watkins
Gail E Besner
Mika A B Matthews
P2860
P304
938-44; discussion 944
P356
10.1016/J.JPEDSURG.2014.01.030
P407
P577
2014-01-31T00:00:00Z